Yasuhiro Hiyoshi

Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non–Small-Cell Lung Cancer: A Prospective Observational Study

Tomoya Fukui, Yuriko Okuma, Yoshiro Nakahara et al. · Clinical Lung Cancer · 2018 · 107 citations

Medicine, Immunology, Oncology +16

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer

Masayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara et al. · PLoS ONE · 2019 · 41 citations · Full text

Medicine, Oncology, Metastasis +10

Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer

Satoshi Igawa, Yuichi Sato, Shinichiro Ryuge et al. · Oncology · 2017 · 38 citations

Medicine, Oncology, Pathology +17

Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer

Tomoya Fukui, Michiko Itabashi, Mikiko Ishihara et al. · BMC Cancer · 2016 · 29 citations · Full text

Medicine, Oncology, Chemotherapy +10

Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer

Masayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara et al. · Cancer Management and Research · 2018 · 29 citations · Full text

Medicine, Oncology, Surgical Oncology +12